Evidence map›Paper›PMID 36405610›Full record

ArticleFrontiers in medicine2022

Using machine learning models to predict the duration of the recovery of COVID-19 patients hospitalized in Fangcang shelter hospital during the Omicron BA. 2.2 pandemic.

Yu Xu, Wei Ye, Qiuyue Song, Linlin Shen, Yu Liu, Yuhang Guo, Gang Liu, Hongmei Wu, Xia Wang, Xiaorong Sun and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Yu XuRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Wei YeDepartment of Health Statistics, Army Medical University, Chongqing, China.
Qiuyue SongDepartment of Health Statistics, Army Medical University, Chongqing, China.
Linlin ShenRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Yu LiuRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Yuhang GuoRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Gang LiuRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Hongmei WuRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Xia WangRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Xiaorong SunRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Li BaiRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Chunmei LuoNational Exhibition and Convention Center Fangcang Shelter Hospital, Shanghai, China.
Tongquan LiaoNational Exhibition and Convention Center Fangcang Shelter Hospital, Shanghai, China.
Hao ChenNational Exhibition and Convention Center Fangcang Shelter Hospital, Shanghai, China.
Caiping SongNational Exhibition and Convention Center Fangcang Shelter Hospital, Shanghai, China.
Chunji HuangNational Exhibition and Convention Center Fangcang Shelter Hospital, Shanghai, China.
Yazhou WuDepartment of Health Statistics, Army Medical University, Chongqing, China.
Zhi XuRespiratory and Critical Care Medical Center, Xinqiao Hospital, Army Medical University, Chongqing, China.
Army Medical University · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Factors that may influence the recovery of patients with confirmed SARS-CoV-2 infection hospitalized in the Fangcang shelter were explored, and machine learning models were constructed to predict the duration of recovery during the Omicron BA. 2.2 pandemic. Methods: A retrospective study was conducted at Hongqiao National Exhibition and Convention Center Fangcang shelter (Shanghai, China) from April 9, 2022 to April 25, 2022. The demographics, clinical data, inoculation history, and recovery information of the 13,162 enrolled participants were collected. A multivariable logistic regression model was used to identify independent factors associated with 7-day recovery and 14-day recovery. Machine learning algorithms (DT, SVM, RF, DT/AdaBoost, AdaBoost, SMOTEENN/DT, SMOTEENN/SVM, SMOTEENN/RF, SMOTEENN+DT/AdaBoost, and SMOTEENN/AdaBoost) were used to build models for predicting 7-day and 14-day recovery. Results: Of the 13,162 patients in the study, the median duration of recovery was 8 days (interquartile range IQR, 6-10 d), 41.31% recovered within 7 days, and 94.83% recovered within 14 days. Univariate analysis showed that the administrative region, age, cough medicine, comorbidities, diabetes, coronary artery disease (CAD), hypertension, number of comorbidities, CT value of the ORF gene, CT value of the N gene, ratio of ORF/IC, and ratio of N/IC were associated with a duration of recovery within 7 days. Age, gender, vaccination dose, cough medicine, comorbidities, diabetes, CAD, hypertension, number of comorbidities, CT value of the ORF gene, CT value of the N gene, ratio of ORF/IC, and ratio of N/IC were related to a duration of recovery within 14 days. In the multivariable analysis, the receipt of two doses of the vaccination vs. unvaccinated (OR = 1.118, 95% CI = 1.003-1.248; Conclusion: Age and vaccination dose were factors robustly associated with accelerated recovery both on day 7 and day 14 from the onset of disease during the Omicron BA. 2.2 wave. The results suggest that the SMOTEEN/RF-based model could be used to predict the probability of 7-day and 14-day recovery from the Omicron variant of SARS-CoV-2 infection for COVID-19 prevention and control policy in other regions or countries. This may also help to generate external validation for the model.

Indexed as

COVID-19Fangcang sheltermachine learning modelomicronvaccination

Identifiers

PMID36405610
PMCPMC9666500
OpenAlexW4308124606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.